secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2023-12-08T23:59:59+00:00
Accession:  0001104659-23-124739
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransCode Therapeutics amends bylaws, reduces stockholder quorum from majority to one-third
--------------------------------------------------------------------------------

- Board approved amendment to Amended and Restated Bylaws on Dec 8, 2023.
- Quorum for stockholder meetings reduced to one-third of outstanding shares entitled to vote.
- Amendment also revises procedures for adjournment of stockholder meetings.
- Effective immediately upon adoption; amends Sections 4(e) and 5 of Article I.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465923124739/0001104659-23-124739-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465923124739/tm2332527d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-124739

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer